Dermapharm Holding SE reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 959.6 million compared to EUR 807.64 million a year ago. Net income was EUR 209.58 million compared to EUR 85.83 million a year ago. Basic earnings per share from continuing operations was EUR 3.89 compared to EUR 1.59 a year ago. Diluted earnings per share from continuing operations was EUR 3.89 compared to EUR 1.59 a year ago.